Use of CGM in Kidney Transplant Recipients

Recruiting now · Not applicable

Conditions studied: Kidney Transplant; Complications, Diabetes Mellitus, Type 2, Insulin Dependent Diabetes

In brief

The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.

Key facts

Study ID

NCT04783441

Run by

University of California, Davis

People needed

80

Starts

2021-06-29

Expected to finish

2026-12-31

Last updated by the study team

2026-01-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 or above
• Received a kidney transplant within the past year with functioning kidney (eGFR > 30 mL/min
• Person with Type 2 Diabetes and on insulin
• Access to home wi-fi connection

You may not qualify if…

• Person with Type 1 Diabetes
• Patients taking hydroxyurea
• Patient unable to wear the Dexcom G6 device at all times for any reason
• Must be able to test blood glucose with meter 4x a day when on blinded CGM.
• Presence of clinically significant visual or cognitive impairment
• Illiterate
• Prisoners
• Women who are pregnant, who plan to become pregnant during the course of the study, or who are breastfeeding
• Presence of clinically unstable cardiovascular disease
• Active malignancy treatment

Where it is running

• UC Davis Health — Sacramento, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.